DGNMF (Diagnamed Holdings) Total Stockholders Equity: $-0.13 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Diagnamed Holdings Total Stockholders Equity?

Diagnamed Holdings DGNMF -6.85% Total Stockholders Equity is $-0.13 Mil as of Jun. 2026. The stock has 1 warning sign investors should review.

Diagnamed Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $-0.13 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Diagnamed Holdings's Book Value per Share for the quarter that ended in Jun. 2026 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Diagnamed Holdings's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.00.

Diagnamed Holdings  (OTCPK:DGNMF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Diagnamed Holdings's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-0.127-0)/131.609
=-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Diagnamed Holdings's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / -0.127
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnamed Holdings Total Stockholders Equity Related Terms

Diagnamed Holdings Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Diagnamed Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnamed Holdings Total Stockholders Equity Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
Total Stockholders Equity
1.77 0.93 0.17 -0.20 -0.33

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.33 -0.20 -0.07 -0.13
What does a Total Stockholders Equity of $-0.13 Mil mean?
Diagnamed Holdings (DGNMF) has a Total Stockholders Equity of $-0.13 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Diagnamed Holdings and its competitors.
Is Diagnamed Holdings' Total Stockholders Equity too high?
Diagnamed Holdings' current Total Stockholders Equity is $-0.13 Mil.
How does Diagnamed Holdings' Total Stockholders Equity compare to VEEV and BTSG?
Diagnamed Holdings' Total Stockholders Equity of $-0.13 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Diagnamed Holdings and its competitors. Diagnamed Holdings's current Total Stockholders Equity is $-0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnamed Holdings stock overvalued right now?
Diagnamed Holdings (DGNMF) has a current Total Stockholders Equity of $-0.13 Mil. The current Total Stockholders Equity is $-0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Diagnamed Holdings (DGNMF), the current Total Stockholders Equity is $-0.13 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnamed Holdings Business Description

Other Exchanges DMED:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its products include, CERVAI which is a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It is also investigating other technological applications such as BrainAge and BrainTremor.